Gynaecology Specialist
Dr Salleha Khalid received her Medical Degree from Universiti Putra Malaysia in 2004. After completing her training as a house officer at Kuala Lumpur General Hospital, she moved to the United Kingdom in 2005 to continue her training in Obstetrics & Gynaecology (O&G). Upon returning from the UK in 2010, she joined Universiti Sains Islam Malaysia as medical lecturer and continued her clinical service in the O&G Department, Hospital Ampang.
She received her MRCOG specialist qualification from the Royal College of Obstetricians and Gynaecologists in the United Kingdom in 2014 and was gazetted as an O&G specialist by the Ministry of Health the following year.
Dr Salleha then pursued sub-specialty training in Reproductive Medicine in 2016, beginning with a Fellowship in Minimally Invasive Surgery at Putrajaya Hospital’s O&G department, followed by a Fellowship in Reproductive Medicine and Fertility at Hospital Canselor Tuanku Mizan’s Medically Assisted Conception (MAC) unit (UKM). She then continued her fellowship training as a Clinical Fellow in Sexual Reproductive Health at the Newcastle Fertility Center in the United Kingdom, where she was later certified in Assisted Conception by the British Fertility Society in 2019.
Following the completion of the sub-speciality training, Dr Salleha joined Sophea Fertility Centre in 2020 as a Fertility Specialists where she continues to exclusively focus her practice in Reproductive Medicine. Since then, Dr. Salleha has used social media to raise awareness about fertility and women’s health in general. She aims to remove the stigma surrounding these topics and empower women to take control of their well-being. Her informative posts and practical tips have been widely appreciated by followers. By dispelling down taboos and myths, Dr. Salleha is enabling women to make informed choices about their health.
Soon after, Dr. Salleha realized the need for a more inclusive and comprehensive gynaecological services dedicated to sexual health. As a result, she established Femina in 2023 to broaden the clinical offerings currently available for women, which provides a wide range of non-invasive treatment options tailored to the specific needs of each patient.